Cigna (CI) January 2025 Valuation Model and Risk Framework

Cigna (CI) January 2025 Valuation Model and Risk Framework
 
This Cigna (CI) valuation model includes a sum-of-the-parts (SOTP) valuation, financial forecasts, segment breakdown, and detailed operating model. Assumptions can easily be adjusted by the user.
 
Cigna: The Cigna Group operates as a global health company. The Company offers integrated behavioral,  medical, and pharmacy management solutions, as well as provides life, accident, disability,  supplemental, Medicare, and dental insurance products and services. The Cigna Group serves individuals, families, and businesses worldwide.
 
Cigna stands to be the largest beneficiary from Humira biosimilars as an insurer
Acquisition of ESRX created a vertically integrated player with better ability to manage medical and pharmacy spend to drive significant savings for members
Flexible balance sheet to deploy into M&A
Opportunity to upsell dental and vision ancillary services can help drive accelerated commercial penetration longer-term
Opportunity for further MA penetration remains as co. can cross sell in areas it has strong commercial presence
 
Long Term Risks: healthcare regulation and PBM pricing risk
 
Overall SSR Risk Ranking: 3.75 out of 5 (High)
 
See more analysis in the model attached.
 
NOT FINANCIAL ADVICE - FOR EDUCATIONAL USE ONLY
 
Free to Silver and Gold subscribers (see Plans & Pricing): https://www.specialsitsresearch.com/plans-pricing